We may earn an affiliate commission when you visit our partners.

Clinical Research Manager

Save
April 2, 2024 Updated April 16, 2025 14 minute read

Clinical Research Manager: A Comprehensive Career Guide

A Clinical Research Manager (CRM) plays a pivotal role in the development of new medical treatments, devices, and diagnostic tools. They oversee the planning, execution, and completion of clinical trials, ensuring these studies adhere to strict scientific, ethical, and regulatory standards. Think of them as the project managers specifically for the complex world of testing new healthcare innovations on human participants.

Share

Help others find this career page by sharing it with your friends and followers:

Salaries for Clinical Research Manager

City
Median
New York
$185,000
San Francisco
$200,000
Seattle
$124,000
See all salaries
City
Median
New York
$185,000
San Francisco
$200,000
Seattle
$124,000
Austin
$163,000
Toronto
$150,000
London
£82,000
Paris
€64,000
Berlin
€75,000
Tel Aviv
₪434,000
Singapore
S$108,000
Beijing
¥616,000
Shanghai
¥216,000
Shenzhen
¥231,000
Bengalaru
₹579,000
Delhi
₹754,000
Bars indicate relevance. All salaries presented are estimates. Completion of this course does not guarantee or imply job placement or career outcomes.

Reading list

We've selected some books that we think will supplement your learning. Use these to develop background knowledge, enrich your coursework, and gain a deeper understanding of the topics covered in Clinical Research Manager.
Known universally across medical schools and fellowship programs as the Hulley and Cummings manual, this fifth edition guides investigators through formulating FINER research questions, cohort and randomized designs, sample size estimation, and IRB ethics.
Serving as the gold-standard reference on randomized controlled trial methodology, Friedman, Furberg, DeMets, Reboussin, and Granger detail blinding, covariate-adaptive randomization, interim Data Monitoring Committees, and intent-to-treat analysis.
Originating from the flagship National Institutes of Health (NIH) Clinical Center training course, Gallin, Ognibene, and Johnson synthesize regulatory FDA IND filings, Good Clinical Practice (GCP), biostatistics, and translational protocol management.
Distilling their celebrated Lancet epidemiology series, CONSORT co-author Kenneth Schulz and David Grimes clarify allocation concealment, selection bias, multiplicity pitfalls, and non-inferiority trials with lucid clinical examples.
Fayers and Bee Choo Tai bridge pragmatic trial operations with statistical reporting, covering cluster-randomized trials, quality-of-life patient-reported outcomes, missing data imputation, and CONSORT compliance.
Examines antimicrobial resistance through the lens of the 'One Health' concept, highlighting the interconnectedness of human, animal, and environmental health. It is crucial for understanding the multi-faceted nature of AMR and the need for interdisciplinary approaches. It is particularly relevant given the course names that mention One Health.
Underpowered clinical trials waste patient lives and research funding. Chow, Shao, Wang, and Lokhnygina provide exact power and sample-size formulas for superiority, equivalence, adaptive, and bioequivalence designs.
Explores the profound impact of antibiotic overuse on the human microbiome and its potential links to various modern diseases, including those influenced by antimicrobial resistance. It provides valuable context on the broader ecological consequences of antibiotic use. It is an important read for understanding the 'why' behind the AMR crisis beyond just the microbiological mechanisms.
Pharmaceutical biostatisticians and clinical data programmers rely on Walker and Shostak to execute analysis of covariance, Kaplan-Meier survival curves, Cox proportional hazards, and categorical exact tests in SAS.
This report outlines key research areas at the interface of human, animal, plant, and environmental health to combat AMR, reflecting the One Health approach. It crucial document for understanding current research priorities and future directions in the field. It is particularly relevant for those interested in the research and policy aspects of One Health and AMR.
Operationalizing ICH E6(R2/R3) Good Clinical Practice in the field, Woodin and Schneider train Clinical Research Associates in source document verification, risk-based monitoring, informed consent audits, and serious adverse event reporting.
Renowned biostatistician Stephen Senn analyzes AB/BA and Latin-square crossover designs, washout period carryover effects, and within-patient variance reduction in chronic disease trials.
Provides a compelling and accessible narrative about the rise of MRSA, a well-known example of antimicrobial resistance. It is particularly useful for gaining a broad understanding of how antibiotic resistance emerges and spreads, and the human stories behind it. It serves as excellent background reading for anyone new to the topic.
Provides evidence-based guidance on the appropriate use of antibiotics based on the WHO's AWaRe classification system. It practical resource for healthcare professionals and public health practitioners focused on optimizing antibiotic use to combat resistance. It is particularly relevant for antimicrobial stewardship efforts.
Harry Yang and Liang Zhao examine decentralized trial architectures, real-world evidence integration, AI-assisted patient recruitment, and Bayesian adaptive designs transforming contemporary drug development.
Group-sequential stopping rules, sample-size re-estimation, and seamless Phase II/III pick-the-winner platform trials accelerate drug development when backed by Mark Chang's Monte Carlo operating characteristic simulations.
Provides an overview of the problems associated with antibiotic resistance and explores potential solutions from various perspectives. It good resource for gaining a comprehensive understanding of the multifaceted challenges and the range of proposed interventions. It is suitable for a broad audience interested in the AMR crisis.
Providing a practical site-level reference for study coordinators and research nurses, Norris covers investigator site files, case report form completion, investigational product accountability, and FDA audit readiness.
Delves into the interconnectedness of antimicrobial resistance and bacterial virulence, providing a more in-depth look at the biological mechanisms involved. It is suitable for those seeking a deeper scientific understanding of how bacteria become resistant and cause disease. It is valuable for advanced students and researchers.
While covering a broader scope of infectious diseases, this book dedicates significant attention to the threat of antimicrobial resistance as a major public health emergency. It provides a high-level overview of the challenges and potential solutions, making it suitable for gaining a broad understanding and appreciating the urgency of the topic. It is valuable for putting AMR into the larger context of global health threats.
Explores collaborative approaches to controlling antimicrobial resistance, highlighting the importance of multi-sectoral efforts. It useful resource for understanding the need for cooperation across different fields and regions to effectively address AMR. It is relevant for those interested in public health and policy interventions.
Co-authored by Cochrane Collaboration founder Sir Iain Chalmers, Imogen Evans, Hazel Thornton, and Paul Glasziou, this vivid narrative illustrates why unblinded clinical intuition repeatedly harms patients until tested in fair trials.
Discusses the ongoing challenge of antibiotic-resistant bacteria, covering various aspects including assessment of resistance and mechanisms involved. It provides insights into the persistent nature of AMR and the scientific efforts to combat it. It is suitable for those seeking a more technical understanding of the issue.
Physician and AllTrials campaigner Ben Goldacre exposes publication bias, selective outcome switching, and ghostwritten clinical trial reports, showing why compulsory trial registration is vital to medical integrity.
This textbook offers a comprehensive exploration of epidemiological methods with recent examples, making it a valuable resource for understanding how AMR is studied in populations. It is suitable for both students and practitioners in public health and clinical medicine.
Similar to other epidemiology textbooks, this book provides foundational knowledge in epidemiological principles and their application to public health issues, including infectious diseases and outbreaks. It solid resource for students needing to build their epidemiological understanding relevant to AMR.
This widely used textbook provides a strong foundation in the principles and methods of epidemiology, which are essential for understanding the spread and control of infectious diseases, including antibiotic-resistant infections. While not specific to AMR, a solid grasp of epidemiology is crucial for anyone working in this field. It standard text in public health programs.
Table of Contents
Our mission

OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.

Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.

Find this site helpful? Tell a friend about us.

Affiliate disclosure

We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.

Your purchases help us maintain our catalog and keep our servers humming without ads.

Thank you for supporting OpenCourser.

© 2016 - 2025 OpenCourser